Norges Bank’s Bristol-Myers Squibb Co Position
Does Norges Bank own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 36.10M shares worth $1.9B in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1.9B
Q4 2025
Shares
36.10M
% of Portfolio
+0.21%
Quarters Held
23
position exited
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 36.10M | $1.9B | +0.21% |
| Q2 2025 | 33.57M | $1.6B | +0.19% |
| Q1 2025 | 32.25M | $1.7B | +0.28% |
| Q4 2024 | 35.18M | $2.0B | +0.26% |
| Q3 2024 | 27.82M | $1.6B | +0.33% |
| Q2 2024 | 60.11M | $3.1B | +0.26% |
| Q1 2024 | 27.38M | $1.9B | +0.42% |
| Q4 2023 | 30.41M | $1.6B | +0.27% |
| Q3 2023 | 23.86M | $1.7B | +0.45% |
| Q2 2023 | 20.21M | $1.6B | +0.40% |
| Q4 2022 | 26.04M | $1.9B | +0.45% |
| Q3 2022 | 23.05M | $1.4B | +0.30% |
| Q2 2022 | 23.78M | $1.6B | +0.34% |
| Q1 2022 | 25.11M | $1.6B | +0.36% |
| Q3 2021 | 22.62M | $1.4B | +0.36% |
| Q2 2021 | 22.61M | $1.3B | +0.38% |
| Q1 2021 | 27.28M | $1.5B | +0.54% |
| Q3 2020 | 17.77M | $901M | +0.28% |
| Q2 2020 | 17.15M | $778M | +0.24% |
| Q1 2020 | 17.14M | $818M | +0.26% |
| Q3 2019 | 15.17M | $942M | +0.31% |
| Q2 2019 | 15.12M | $837M | +0.29% |
| Q1 2019 | 15.08M | $954M | +0.35% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of BMY.